Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass

Clinical trial NCT02025621 · COMPLETED

Trial details

NCT number: NCT02025621
Sponsor: Tenax Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Bypass Grafting Mitral Valve Surgery Low Cardiac Output Syndrome

Start date: 2014-07-01
Primary completion: 2016-11-01
Enrollment: 882

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.